Cuprina (Cayman) Limited (CUPR)
NasdaqCM: CUPR
· Echtzeitkurs · USD
3.09
+0.09 (3.00%)
Zum Schluss: Aug 13, 2026, 3:07 PM
Cuprina (Cayman) Limited (CUPR) Stock Price, Analysis & Data
3.00% (1D)
| Geld | 2.16 |
| Marktkapitalisierung | 8.29 Mio |
| Umsatz (TTM) | 49.89K |
| Nettogewinn (TTM) | -4.67 Mio |
| Beta | n/a |
| EPS (ttm) | -1.43 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 2.08 |
| KUV (TTM) | 166.05 |
| Earnings Date | n/a |
| Brief | 3.9 |
| Volumen | 16,830 |
| Ø Vol. (20D) | 3,139,457 |
| Eröffnung | 3.13 |
| Vortagesschluss | 3.00 |
| Tagesspanne | 2.93 - 3.13 |
| 52-Wk Range | 1.76 - 76.00 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über CUPR
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hyd...
Branche Medical Instruments & Supplies
Sektor Healthcare
IPO Datum Apr 10, 2025
Mitarbeiter 10
Börse NasdaqCM
Tickersymbol CUPR
Website https://www.cuprina.com.sg
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Cuprina (Cayman) 49.89K, ein Anstieg von 3.26% im Vergleich zum Vorjahr (48.32K). Der Gewinn lag bei -4.67 Mio, ein Anstieg von 199.48 %.
Finanzberichte